Menu
  • Join
  • Login
  • Contact
 

Search abstracts


PHARMACOGENOMIC INFORMATION IN OFFICIAL DRUG LABELLING

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: AZZOPARDI, Yasmine (University of Malta, Faculty of Medicine and Surgery, Malta)
  • Co-author(s): Yasmine Azzopardi: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
    Francesca Wirth: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
    Liberato Camilleri: Department of Statistics and Operations Research, Faculty of Science, University of Malta, Msida, Malta
    Anthony Serracino-Inglott: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta;, Malta Medicines Authority, Malta Life Sciences Park, San Gwann, Malta
    Lilian M Azzopardi: Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
  • Abstract:

    Background

    Harmonisation of pharmacogenomic (PGx) information in drug labelling between regulatory bodies facilitates clinical implementation of PGx.

    Methods

    The FDA drug label and EMA Summary of Product Characteristics (SmPC) of 70 drugs with PGx implications in four disease categories (malignancy and immunosuppression, infections, cardiovascular

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses